AKT1 and prostate carcinoma: Cancer stem cell signatures enhance metastatic propensity [39] through cancer stem cell stemness via the PI3K/AKT, ERK/MAPK, and WNT/β-catenin pathways in colon, gastric, and prostate cancers [40,41].